Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Comparative in vitro activities of cefmenoxime (SCE-1365) and newer cephalosporin derivatives of clinical utility.

Literature DB >> 6287933

Comparative in vitro activities of cefmenoxime (SCE-1365) and newer cephalosporin derivatives of clinical utility.

V I Ahonkhai, C E Cherubin, M A Shulman, U Bancroft.

Abstract

The minimal inhibitory concentrations of cefmenoxime (SCE-1365), cefotaxime, cefoperazone, and moxalactam against various species of aerobic bacteria were determined. The activities of cefmenoxime, cefotaxime, and moxalactam were generally similar and slightly higher than the activity of cefoperazone.

Entities: Chemical

Mesh：

Substances：

Year: 1982 PMID： 6287933 PMCID： PMC182061 DOI： 10.1128/AAC.21.6.999

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

4 in total

1. Antimicrobial activity and spectrum of cefoperazone against recent clinical isolates.

Authors: R N Jones; P C Fuchs; A L Barry; T L Gavan; E H Gerlach; H M Sommers
Journal: Clin Ther Date: 1980 Impact factor: 3.393

2. Cefmenoxime (SCE-1365), a novel broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities.

Authors: K Tsuchiya; M Kondo; M Kida; M Nakao; T Iwahi; T Nishi; Y Noji; M Takeuchi; Y Nozaki
Journal: Antimicrob Agents Chemother Date: 1981-01 Impact factor: 5.191

3. Beta-lactamase stability and antibacterial activity of cefmenoxime (SCE-1365), a novel cephalosporin.

Authors: K Okonogi; M Kuno; M Kida; S Mitsuhashi
Journal: Antimicrob Agents Chemother Date: 1981-08 Impact factor: 5.191

4. Antimicrobial activity of cefmenoxime (SCE-1365).

Authors: J M Stamm; R L Girolami; N L Shipkowitz; R R Bower
Journal: Antimicrob Agents Chemother Date: 1981-03 Impact factor: 5.191

4 in total

7 in total

1. Influence of growth medium on the in vitro activities of second- and third-generation cephalosporins against Streptococcus faecalis.

Authors: D F Sahm; C N Baker; R N Jones; C Thornsberry
Journal: J Clin Microbiol Date: 1984-09 Impact factor: 5.948

2. Cefmenoxime therapy of serious bacterial infections.

Authors: M E Gombert; L A Glasser; R H Eng
Journal: Antimicrob Agents Chemother Date: 1984-04 Impact factor: 5.191

3. In vitro activity of cefodizime (HR-221).

Authors: V I Ahonkhai; C E Cherubin; M A Shulman
Journal: Antimicrob Agents Chemother Date: 1982-10 Impact factor: 5.191

4. Relationship between the bactericidal and bacteriolytic activity of cephalosporins and changes in the cell volumes of Escherichia coli cultures.

Authors: E Schulz; L von Klitzing; R Marre; K Sack
Journal: Infection Date: 1985 Sep-Oct Impact factor: 3.553